Please login to the form below

Using human insights to push healthcare communications forward

This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives

Patient perspectives is a fast-moving field of healthcare communications that gives precedence to the thoughts, opinions, and feelings a person may have about their condition. Across the healthcare landscape, the notion is widely accepted. After all, if we are to help people with their conditions, we must understand how that condition affects them. While overall, the industry is doing well to put humans at the heart of their own care, an accurate and nuanced understanding of patient perspectives can offer real insights into the delivery of better healthcare communications.

Firstly, generating patient perspectives has two sides, one which benefits the patiennt and others like them, and one which benefits the doctors and other industry professionals.

So, with all these benefits human insights seem like a win/win, clear strategy that everyone should implement. While the benefits are clear, the routes to amassing this information, and moreover collecting information that can be transformed into actionable insights is considerably less obvious. However, there are a couple of key things you can consider when trying to navigate your way around this area.

Seeing beyond the patient

Although this might seem counterintuitive, you should strive to reach those who have minimal healthcare knowledge. After all, if someone inexperienced in seeking health information finds clarity in your materials, you can say with conviction that you’ve considered the varying levels of health literacy. From there, you can involve the people that are important to the patients life. Their family, friends or carers can often offer key insights on the effectiveness a medication may have on their condition, the usability of the packaging, or the clarity of the instructions. This information is all key if we as an industry are to continue bettering drug development for the future of disease control, prevention, and cure.

Speaking with, not at the patient

While doctors and scientists have in-depth medical knowledge on a range conditions, right down to the molecular make-up of a disease, it is important to understand how a condition affects somebody’s life. Therefore, it remains crucial to implement the health seeker in all stages of drug development and consider the way in which they understand a drug and its effectiveness. Even if they believe their symptoms may be related to something that bears no medical correlation to their condition, knowing this can often inform what symptoms affect them most, while also aiding how best to create materials that dispel myths about their condition. However, there’s no need to obsess over materials being scientifically precise, provided they can be interpreted safely. Being too technical can overwhelm health seekers as the information is neither helpful nor relevant to the lived reality of their condition. Accurate yet accessible is the balance we should always aim to achieve.

Understanding which leads to insight

Perhaps most crucially, when it comes to generating insights, it is important to understand how health seekers feel, both physically and mentally. If we can better understand the way their condition affects their life, we can develop drugs that not only have clinical efficacy, but also provide better quality of life. Today’s healthcare market is saturated with products and services, meaning health seekers have a variety of safe and effective treatment options available to them. What will set those options apart will be the meaningful impact they have on every aspect of a person’s life, beyond symptom management.

Making time to listen is all it takes

Whether you’re considering a user test, panel workshops, questionnaire or even just talking to health seekers, the above considerations can always be implemented to make these interactions beneficial for both parties. Whether a doctor looking for more insights on how to better manage health conditions or a clinical study team evaluating the efficacy of a new drug, at the heart of both is the health seeker’s welfare. Most pharma companies understand and accept that insights are the way forward when it comes to brand recognition, uptake and adherence to prescribed courses of action or treatment. Yet most struggle to adapt current marketing practices to achieve a more holistic view of the health seeker and increase engagement with him or her on a deeper, more personal level.

If we can learn to listen effectively, compassionately and sincerely, we can begin to build insights into every aspect of the health seeker’s journey, ultimately improving their experience of the healthcare they receive, and their life on a wider level.

18th November 2019

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

New from the PhRMA: Diversity in clinical trials principles summarised
In November 2020, PhRMA announced the first-ever, industry-wide principles on clinical trial diversity. The principles were approved by the PhRMA Boards of Directors and will take effect in April 2021.
COUCH Health
New from the FDA: Diversity in clinical trials guidance summarised
In November 2020, the FDA released guidance to enable greater diversity in clinical trials through changes to eligibility criteria, enrolment practices, and trial designs.
COUCH Health
5 steps to effective clinical trial branding
When recruiting patients for your clinical trial, you want the materials and information around it to be seen as reputable and professional. To make it clear what the clinical trial is about and to ensure consent is informed. And be something that people are going to remember. And with some trials lasting years, building awareness and familiarity is key to improve engagement. That’s where your clinical trial branding comes in…
COUCH Health
October 2020: diversity and inclusion in clinical trials round-up
In our latest round-up of news surrounding diversity and inclusion in clinical trials, we take a closer look into the benefits that diversity can bring to society, learnings that we can take from the COVID-19 pandemic to shift our thinking around diversity and clinical trials, how we can address long-standing barriers to build trust in healthcare, and much more.
COUCH Health
Live panel discussion: Should diverse representation in UK clinical trials be mandatory?
This online event is being held by Innovative Trials, COUCH Health, and Egality Health.  Three organisations who are working to improve diversity in clinical trials.
COUCH Health
What are the biggest barriers in patient recruitment?
With the advances that have been made in clinical research, it’s almost hard to believe that the same challenges still exist within patient recruitment. Unfortunately, traditional clinical research models pose challenges at many levels and ultimately hinder the efficient running of clinical trials.
COUCH Health